Traynor Capital Management’s NervGen Pharma NGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding NGEN
Traynor Capital Management's NGEN Position: Q3 2026 in Review
Traynor Capital Management held its NervGen Pharma (NGEN) position steady in Q3 2026 at 31,500 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #319.
Traynor Capital Management first reported a position in NGEN in Q1 2026 and has held it in 3 quarters since. The position peaked at $95.1K in Q1 2026. 68 funds tracked by Wall St. Rank hold NGEN as of Q3 2026.
- Traynor Capital Management held 31,500 shares of NervGen Pharma worth $60.2K as of Q3 2026.
- Traynor Capital Management left its NervGen Pharma share count unchanged in Q3 2026.
- NervGen Pharma made up ﹤0.01% of Traynor Capital Management's portfolio in Q3 2026, its #319 holding.
- Traynor Capital Management first reported a position in NervGen Pharma in Q1 2026 and has held it in 3 quarters since.
- Traynor Capital Management's NervGen Pharma position peaked at $95.1K in Q1 2026.
- 68 funds tracked by Wall St. Rank held NervGen Pharma as of Q3 2026.
Based on Traynor Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.